PATENT CLAIM ANALYSIS

Application Number: 15904984
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["422", "069000"]

Abstract:
Provided are devices, systems and methods for evaluation of hemostasis. In some embodiments, an apparatus is disclosed comprising a housing; a plurality of test chambers located in the housing, the plurality of test chambers including chambers configured for measurements via a system that interrogates one or more viscoelastic properties of test samples in the test chambers, wherein the one or more viscoelastic properties is used to characterize dynamics of coagulation and/or fibrinolysis.

Claim (Index 74):
An apparatus comprising:\n a housing; a plurality of test chambers located in the housing, the plurality of test chambers including chambers configured for measurements via a system that interrogates one or more viscoelastic properties of test samples in the test chambers, wherein the one or more viscoelastic properties is used to characterize dynamics of coagulation and/or fibrinolysis, wherein the plurality of test chambers comprise a first test chamber and a second test chamber, each of the first test chamber and the second test chamber having reagents that interact with a test sample of blood received therein; and a fluid pathway comprising a plurality of channels, each defined at least in part by the housing, wherein the fluid pathway includes an inlet, defined at least in part by the housing, through which the test sample is introduced into the apparatus, wherein at least one channel of the fluid pathway is in communication with the inlet and with the first test chamber and a second test chamber to deliver a portion of the test sample to each of the first test chamber, wherein the at least one channel of the fluid pathway includes an inlet channel, a first channel, and a second channel, wherein the inlet channel is in communication with the inlet, and wherein the first channel is in communication with the inlet channel and at least with the first test chamber, and wherein the second channel is in communication with the inlet channel and at least with the second test chamber; wherein the first test chamber comprises a first reagent or a first combination of reagents that interact with the blood received therein, wherein the first reagent, or a reagent included in the first combination of reagents, is configured to activate coagulation; and wherein the second test chamber comprises a second combination of reagents that interact with blood of the test sample received therein, wherein the second combination of reagents includes i) a reagent, or a combination of reagents, configured to activate coagulation and ii) a reagent, or a combination of reagents, configured to inhibit platelet aggregation.

Metadata:
- Claim Count in Document: 93.0
- Percentile: 88.0
- Lexical Diversity: 1.58
- Patent Class: 422.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15644124', '15202059', '13397398', '14866316', '14500248']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7939340614660189
- 35 USC 102 Novelty (BERT): 0.5631357923902777
- Combined Prediction Score: 0.7708542345584448
- Mean Citation Score: 383.205042
- Max Citation Score: 481.45563
- Similarity Product: 413.6972112625981

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test